Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
13.8M
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
704K
-
Shares change
-
+37.3K
-
Total reported value, excl. options
-
$1.32M
-
Value change
-
+$61.5K
-
Number of buys
-
6
-
Number of sells
-
-7
-
Price
-
$1.87
Significant Holders of Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) as of Q3 2023
19 filings reported holding COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share as of Q3 2023.
Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 704K shares
of 13.8M outstanding shares and own 5.09% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (276K shares), RENAISSANCE TECHNOLOGIES LLC (126K shares), BlackRock Inc. (74.1K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (72.2K shares), GEODE CAPITAL MANAGEMENT, LLC (60.4K shares), MORGAN STANLEY (44.5K shares), STATE STREET CORP (24.4K shares), NORTHERN TRUST CORP (12.2K shares), BANK OF AMERICA CORP /DE/ (9.03K shares), and Tower Research Capital LLC (TRC) (3.35K shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.